Posts

Showing posts from August, 2020

Ubisoft Won't Include Physical Games In UK Collector's Editions For Upcoming Xbox One Titles

Image
Ubisoft has made a change to the Collector's editions on Xbox for three of its most anticipated games. If you pre-ordered the Collector's editions for Assassin's Creed Valhalla, Watch Dogs: Legion, or Far Cry 6 on Xbox, you will now receive a digital copy of the game rather than a physical edition. A short post on a help page found on the UK Ubisoft store website details the change. Ubisoft didn't provide a reason, but it could be related to Xbox's Smart Delivery feature, which grants access to select games on both Xbox One and Xbox Series X. Essentially, you buy a game once to play on both Xbox One and Xbox Series X. All three of these Ubisoft titles support Smart Delivery, so there's only one Collector's edition for each game that will be compatible with both Xbox consoles. Ubisoft has clarified to Polygon that this change doesn't apply to North American customers. Assassin's Creed Valhalla Collector's edition Assassin's Creed V...

Texas Longhorns Trending for Explosive Florida WR?

Image
Explosive Pompano Beach Florida wide receiver Jaden Alexis is set to announce his commitment in the coming weeks. The 5-foot-11, 175-pound speedster caught 49 passes for 894 yards and eight touchdowns as a junior at Monarch HS. The South Florida native will be one of the more dynamic wideouts in the 2021 class. Alexis' evaluation from SI All American: Bottom Line: Alexis is a big-play threat because of his short-area quickness and burst. Very athletic wide receiver that will be difficult to corral during one-on-one situations, particularly after the catch. Adept at beating press coverage and excellent at turning a short screen into a long gain. Several recruiting experts have predicted Alexis will eventually pick the Longhorns.  Alexis would be the second receiver commit for the 2021 class, with a chance to make a great impact in Austin. Texas is also heavily recruiting and trending four-star receiver Ketron Jackson. Jackson is also set to announce his decision in the n...

Trending: Some questions (and answers) about the Microsoft-TikTok deal

Image
Hello and welcome to Trending, Business Insider's weekly look at the world of tech. I'm Matt Weinberger, deputy tech editor out of our San Francisco bureau, filling in for Alexei Oreskovic while he's on vacation. If you want to get Trending in your inbox every Wednesday, just click here. The clock goes tick-tock for TikTok President Donald Trump and Microsoft CEO Satya Nadella REUTERS/Carlos Barria Hello, and welcome to Trending, the Business Insider tech newsletter. As you may have already noticed, I'm not Alexei Oreskovic, your usual host — I'm Matt Weinberger, deputy tech editor out of our San Francisco bureau, filling in for Alexei while he takes some well-deserved time off.  In my day job, I oversee our enterprise tech coverage, which encompasses cloud computing, artificial intelligence, open source software, and productivity (shameless plug: you can read all about it on Hyperscale, my enterprise tech newsletter, which publishes via LinkedIn on Frid...

Trending Market News Friday: Biogen, Mortgage Rates

Image
Stocks were showing a bit of volatility Friday with the Dow threatening to break into the green several times during the session before turning definitively south as the trading day went on.  The Nasdaq was less volatile, dropping consistently and declining 1.8% on the day while the S&P 500 fell 0.5%.  U.S. Household Debt Falls Most in 7 Years American consumer debt fell for the first time in six years, the Federal Reserve Bank of New York said, falling 0.2% to about $34 billion.  The decline in the second quarter was the first since 2014 and the drop is the largest since 2013 as credit card balances alone fell by $76 billion in the quarter, the steepest decline in the history of the data.  Biogen Jumps as FDA Accepts Alzheimer's Treatment Application Shares of drugmaker Biogen (BIIB) - Get Report jumped more than 8% Friday after the Food and Drug Administration accepted the company's marketing application seeking approval for aducanumab, its Alzheim...